{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:15:56Z","timestamp":1760897756158,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.brainresbull.2006.10.017","type":"journal-article","created":{"date-parts":[[2006,11,21]],"date-time":"2006-11-21T12:16:31Z","timestamp":1164111391000},"page":"108-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD"],"prefix":"10.1016","volume":"72","author":[{"given":"Dervila","family":"Glynn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Reim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Brose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Jennifer","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2006.10.017_bib1","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1002\/pmic.200400848","article-title":"Proteome analysis of human substantia nigra in Parkinson's disease","volume":"4","author":"Basso","year":"2004","journal-title":"Proteomics"},{"year":"2002","series-title":"Huntington's Disease","author":"Bates","key":"10.1016\/j.brainresbull.2006.10.017_bib2"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib3","doi-asserted-by":"crossref","first-page":"F969","DOI":"10.1152\/ajprenal.00390.2003","article-title":"PKA-dependent ENaC trafficking requires the SNARE-binding protein complexin","volume":"289","author":"Butterworth","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib4","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterisation of progressive motor deficits in mice transgenic for the Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z","article-title":"Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene","volume":"15","author":"Carter","year":"2000","journal-title":"Movement Disord."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib6","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1523\/JNEUROSCI.19-23-10338.1999","article-title":"Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease","volume":"19","author":"Chai","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/35052017","article-title":"SNARE-mediated membrane fusion","volume":"2","author":"Chen","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11068-004-0514-8","article-title":"Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements","volume":"33","author":"DiProspero","year":"2004","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0306-4522(01)00141-5","article-title":"Cerebellar synaptic protein expression in schizophrenia","volume":"105","author":"Eastwood","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.mp.4000741","article-title":"Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs","volume":"5","author":"Eastwood","year":"2000","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0361-9230(01)00530-5","article-title":"Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins","volume":"55","author":"Eastwood","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0074-7742(04)59003-7","article-title":"The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame?","volume":"59","author":"Eastwood","year":"2004","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.schres.2004.05.010","article-title":"Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons","volume":"73","author":"Eastwood","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib14","doi-asserted-by":"crossref","first-page":"30849","DOI":"10.1074\/jbc.M304615200","article-title":"Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin II","volume":"278","author":"Edwardson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/35040584","article-title":"Identification of genes that modify ataxin-1-induced neurodegeneration","volume":"408","author":"Fernandez-Funez","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainresbull.2003.12.004","article-title":"Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington's disease mutation","volume":"63","author":"Freeman","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib17","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1460-9568.2005.04349.x","article-title":"A similar impairment in CA3 mossy fibre LTP in the R6\/2 mouse model of Huntington's disease and in the complexin II knockout mouse","volume":"22","author":"Gibson","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib18","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/hmg\/ddg249","article-title":"Complexin II is essential for normal neurological function in mice","volume":"12","author":"Glynn","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0006-8993(02)04275-0","article-title":"Overexpression of heat shock protein 70 in R6\/2 Huntington's disease mice has only modest effects on disease progression","volume":"970","author":"Hansson","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib20","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0140-6736(98)03341-8","article-title":"Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia","volume":"352","author":"Harrison","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0166-4328(01)00275-3","article-title":"Development of SHIRPA to characterise the phenotype of gene-targeted mice","volume":"125","author":"Hatcher","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jnr.20278","article-title":"Downregulation of complexin I and complexin II in the medial thalamus is blocked by N-acetylcysteine in experimental Wernicke's encephalopathy","volume":"79","author":"Hazell","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1471-4159.2002.00804.x","article-title":"The role of dopamine in motor symptoms in the R6\/2 transgenic mouse model of Huntington's disease","volume":"81","author":"Hickey","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00221-005-2357-z","article-title":"Atypical diabetes associated with inclusion formation in the R6\/2 mouse model of Huntington's disease is not improved by treatment with hypoglycaemic agents","volume":"166","author":"Hunt","year":"2005","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diabetes.48.3.649","article-title":"Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes","volume":"48","author":"Hurlbert","year":"1999","journal-title":"Diabetes"},{"year":"2000","series-title":"Principals of Neural Science","author":"Kandel","key":"10.1016\/j.brainresbull.2006.10.017_bib26"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","article-title":"Huntington's disease: a synaptopathy?","volume":"9","author":"Li","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib28","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib29","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0092-8674(95)90239-2","article-title":"Complexins: cytosolic proteins that regulate SNAP receptor function","volume":"83","author":"McMahon","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1471-4159.2001.00059.x","article-title":"Progressive depletion of CPLXII in a transgenic mouse model of Huntington's disease","volume":"76","author":"Morton","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0361-9230(01)00611-6","article-title":"Abnormalities in the synaptic vesicle fusion machinery in Huntington's disease","volume":"56","author":"Morton","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib34","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.3493-03.2004","article-title":"CRE-mediated transcription is increased in Huntington's disease transgenic mice","volume":"24","author":"Obrietan","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/20446","article-title":"Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease","volume":"399","author":"Ona","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0092-8674(01)00192-1","article-title":"Complexins regulate a late step in Ca2+-dependent neurotransmitter release","volume":"104","author":"Reim","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s003359900551","article-title":"Behavioural and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment","volume":"8","author":"Rogers","year":"1997","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.conb.2003.09.011","article-title":"Molecular mechanisms of active zone function","volume":"13","author":"Rosenmund","year":"2003","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib40","article-title":"Decrease of complexin II gene expression and immunolabelling in human temporal lobe epilepsy","volume":"10","author":"Sauvageau","year":"2000","journal-title":"Brain Pathol."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1001\/archpsyc.62.3.263","article-title":"Hippocampal complexin proteins and cognitive dysfunction in schizophrenia","volume":"62","author":"Sawada","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/sj.mp.4000978","article-title":"Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness","volume":"7","author":"Sawada","year":"2002","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib43","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.brainresbull.2006.10.017_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.neuro.26.041002.131412","article-title":"The synaptic vesicle cycle","volume":"27","author":"Sudhof","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.brainresbull.2006.10.017_bib45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923006003194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923006003194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:59:08Z","timestamp":1759780748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923006003194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":45,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0361923006003194"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2006.10.017","relation":{},"ISSN":["0361-9230"],"issn-type":[{"type":"print","value":"0361-9230"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depletion of Complexin II does not affect disease progression in a mouse model of Huntington's disease (HD); support for role for complexin II in behavioural pathology in a mouse model of HD","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2006.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}